Effect of Trilaciclib in the Prevention of Myelosupression in Subjects With Limited-stage Small Cell Lung Cancer
Pharmacosmos A/S
Pharmacosmos A/S
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Washington University School of Medicine
Mayo Clinic
Stanford University
Merck Sharp & Dohme LLC
Ohio State University Comprehensive Cancer Center
Merck Sharp & Dohme LLC
Amgen
Case Comprehensive Cancer Center
Mayo Clinic
G1 Therapeutics, Inc.
Virginia Commonwealth University
Rutgers, The State University of New Jersey
University of Missouri-Columbia
G1 Therapeutics, Inc.
Baylor Research Institute
St. Petersburg State Pavlov Medical University
British Columbia Cancer Agency
University of Arkansas
Karolinska Institutet
University of California, San Diego
University of Reading
Instituto Nacional de Cancer, Brazil
McGill University Health Centre/Research Institute of the McGill University Health Centre